Company intelligence / Profile preview

Imperial Chemical Industries

Ownership: Private
Employees: ~33000
Development stage: Commercial

Overview

Imperial Chemical Industries ("ICI") was a pioneering British chemical conglomerate founded by merger in 1926 that grew into one of the world’s largest producers across chemicals/pharma/agro/polymers/paints sectors before being broken up/sold off between 1990–2008—with its pharma arm becoming Zeneca/AstraZeneca and remaining assets acquired by AkzoNobel. It no longer exists as an independent entity but left a lasting mark on life sciences innovation globally.

Therapeutic areas: OtherCardiovascularOncologyInfectious Diseases
Modalities: small moleculespolymers/plasticsagrochemicalsdyes and fibers
Industry: Pharma

Drug pipeline

1 asset

tamoxifen

Commercial

Indications: Breast cancer, Infertility

Partnerships

DuPont for Dulux paint developmentnumerous collaborations across chemicals sector

Beyond the preview

Go deeper on Imperial Chemical Industries.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Imperial Chemical Industries.

Explore the full profile